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Abstract
Modern biology requires modern genetic concepts equally valid for all discovered mechanisms
of inheritance, either “canonical” (mediated by DNA sequences) or epigenetic. Applying basic
genetic terms such as “gene” and “allele” to protein hereditary factors is one of the necessary
steps towards these concepts. The basic idea that different variants of the same prion protein
can be considered as alleles has been previously proposed by Chernoff and Tuite. In this paper,
the notion of prion allele is further developed. We propose the idea that any prion allele is a
bimodular hereditary system that depends on a certain DNA sequence (DNA determinant) and
a certain epigenetic mark (epigenetic determinant). Alteration of any of these two determinants
may lead to establishment of a new prion allele. The bimodularity principle is valid not only
for hereditary prions; it seems to be universal for any epigenetic hereditary factor.  
Key words: 
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Text
Introduction
All fundamental genetic terms (gene, allele, genotype, mutation, recombination, etc.) were 
introduced just to describe genetic phenomenology and initially lacked any relation to certain types
of biomolecules. After the genetic role of DNA had been demonstrated,1,2 it has been strongly 
believed that all hereditary factors were represented by DNA, and that DNA sequencing was 
enough to unravel the origin of any hereditary differences in any species. As a result, all genetic 
terms became associated with specific processes affecting DNA sequences. Discovery of 
epigenetic, especially protein, inheritance opened a new era in biology and raised a lot of problems
in genetic concepts. The fundamental genetic terms became fuzzy and thus called for 
reconsideration (for a review see refs. 3–5). Modern biology requires modern genetic concepts 
valid for all discovered mechanisms of inheritance, either “canonical” (mediated by DNA 
sequences) or epigenetic. One of the most intriguing epigenetic phenomena is protein inheritance, 
the field of genetics where hereditary factors are represented by proteins.  
Currently, the scope of phenomena related to protein inheritance includes positive feedback by 
means of transcription factors,6–9 cortical inheritance,10 centriole inheritance,11 and hereditary 
prions.12,13 The latter are of special interest, because different variants (strains) of some hereditary 
prions have been disclosed (for a review see refs. 14–17). Each of these variants is a discrete 
hereditary factor and should be described in basic terms of general genetics; so, it is not surprising 
that prions are sometimes viewed as “protein genes”.18–20 Moreover, prionization, as well as prion 
curing, are considered as “protein mutations”, and different variants (native and amyloid) of the 
same prion protein are called alleles.21 In a recent issue of Seminars in Cell and Developmental 
Biology, different variants (native and amyloid) of the same prion protein were called alleles, and 
conversion of the [prion–] state to the [PRION+] state was designated as “protein paramutation”.22 
The term “paramutation” is used when one allele is epigenetically converted after its presence in a 
heterozygote with another allele. Thus, the process of applying basic genetic terms for protein 
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hereditary factors has begun, and it is one of the key conditions necessary for the establishment of 
modern genetic concepts. Along the same lines of reasoning, we will consider different variants of 
the same hereditary prion as prion alleles. Current data concerning hereditary prion alleles are very 
complex and strongly need generalization. The aim of this paper is not to scrutinize the details, but 
to review the basic principles underlying hereditary prion alleles. 
Molecular basics of hereditary prions 
The term “prion” was introduced to designate a small proteinaceous infectious particle produced by 
the PrP protein in mammals.23,24 Prion infectivity is based on prion self-perpetuation via changing 
the native protein isoform into the prion one, and newly appearing prion particles can be transmitted
from one organism to another.25 Taking into account the fact that in animals prions form only in 
somatic tissues, which do not transfer their properties to the descendants originating from the 
generative cells, prions had been considered as infectious agents only until 1994. Later, discovery of
prions in some fungi substantially changed the initial paradigm: fungal prions are usually heritable 
as well.26 In this review we will focus exactly on hereditary prions.
Currently, at least four molecular mechanisms underlying hereditary prion phenomenon are known: 
switch from native to amyloid conformation, positive feedback through protein phosphorylation by 
the MAPK-cascade, reproducible alterations in quaternary protein structure, and positive feedback 
through alterations in primary protein structure (Table 1). The first one has been extensively 
reviewed elsewhere (for a review see refs. 13,27–29), and therefore will be mentioned here just 
briefly. 
Switch from native to amyloid conformation. The term “amyloids” means non-covalent protein 
aggregates that (i) form unbranched fibrils, (ii) possess cross-β-structures, and (iii) have a core 
region extremely resistant to hydrogen/deuterium exchange, proteases, and chemical denaturation.30 
All the above mentioned amyloid properties have been proven for several hereditary prions, at least 
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in vitro (Table 1), 31–38 while for some other prions these properties have been presumed rather than 
proven (for a review see ref. 13). 
Amyloid prion aggregates are self-perpetuating because they induce conformational switch of a 
certain protein from its native to amyloid isoform, thus templating their own reproduction. Different
amyloid templates can be produced on the base of the same native isoform (for a review see ref. 
13). This phenomenon is in good agreement with the fact that the same amyloid prion exists in 
multiple alleles differing from each other in their manifestation.14–17
Heredity of amyloid prions is based on three processes (Fig. 1). The first is prion reproduction: a 
monomeric native protein interacts with a preexisting aggregate, changes its own conformation and 
incorporates into the amyloid fibril. As a result, the fibril elongates. The second process is prion 
multiplication:39 the growing fibril is cleaved into fragments, producing aggregate seeds called 
propagons.40 In most cases, cellular chaperone machinery performs this function; for instance, in the
Saccharomyces yeast, the major role belongs to Hsp104 (for a review see ref. 13). The third process 
is prion inheritance. It is based on prion seed transmission from a cell to its progeny during cell 
division, mating, or hyphae conjugation. 
Infectivity of fungal amyloid prions is typically provided by propagon transmission through 
cytoduction or local anastomoses. Moreover, it can be modeled using protein transformation with in
vitro obtained prion aggregates or cellular lysates from a [PRION+] strain.41–43 Recently, it has been 
also proposed that propagons can be transmitted from cell to cell by extracellular vesicles.44
The most extensively studied amyloid hereditary prion is [PSI+], an aggregated form of Sup35p in 
Saccharomyces cerevisiae.14 In its native conformation, this protein is soluble and functions as a 
component of the translational termination machinery.45,46 Under some rare events with frequency 
about 10-7 per cell,47 it switches to atypically stable conformation, and the altered molecules are 
incorporated in the amyloid (for a review see ref. 39). When such aggregate interacts with the native
Sup35 molecules, it converts them to the prion isoform too, and thus reproduces. Multiplication of 
this prion depends on Hsp104, which cleaves aggregates.39 
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[PSI+] is effectively transmissible through cytoduction, and is stably heritable both mitotically and 
meiotically. It decreases the efficiency of translation termination and behaves as a non-Mendelian 
nonsense suppressor.48 Multiple [PSI+] alleles distinct in their suppressor efficiency, mitotic and 
meiotic stability, the proportion of aggregated Sup35p, the number of aggregates per cell, and some 
other features are described (for a review see refs. 14,15,17,40,49,50). Formation, heritability and 
elimination of [PSI+] depend on various genetic and environmental factors thoroughly discussed in 
prion literature (for a review see refs. 13,27–29). 
About a dozen of other amyloid hereditary prions are known in yeasts and Podospora anserina. The
amyloid domains in these prions are non-homologous, and even distinct in their physical 
characteristics: some of them are N/Q rich, but others are not (for a review see refs. 12,13,18), so, 
the details of amyloid prionization seem to be specific in each case. Amyloid prions have been also 
described in mammals (for a review see ref. 51), but here they are only infectious, not heritable. 
Positive feedback through protein phosphorylation by the MAPK-cascade. This mechanism has
been described in the filamentous fungus Podospora anserina.52,53 The MAPK-cascade is a 
regulatory phosphorylation system typical for all eukaryotes and comprising three sequentially 
functioning protein kinases: MAPKKK, MAPKK and MAPK, where MAPK is phosphorylated by 
MAPKK which in turn is a target for MAPKKK (for a review see ref. 54). P. anserina possesses 
three autonomous MAPK pathways: PaMpk1, PaMpk2 and PaMpk3.55 Activation of the PaMpk1 
pathway results in crippled growth, i.e. in formation of poorly growing female-sterile pigmented flat
mycelium. This phenotype is infectious, and its molecular basic is designated as the C prion.52 
PaMpk1 is normally activated during stationary phase and ceases after return to growth; such 
activation is infectious through local anastomoses for normal recipient strains, but is not heritable 
within the initial mycelium.  However, when this pathway is occasionally triggered during the 
growth phase, it undergoes self-activation (molecules in the ON state activate those in the OFF 
state) and appears to be both infectious and mitotically heritable (Figure 2A).53 So, at least two 
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different forms of C are currently known: one is both infectious and mitotically heritable, and the 
other is only infectious.53
It is unclear which element of the PaMpk1 pathway directly corresponds to C. C manifestation 
requires all three genes of the pathway (PaASK1, PaMKK1, and PaMPK1) and can be induced in 
the normally growing mycelium when any of them is overexpressed.53,55,56 So, it is possible that C is 
determined by the state of the PaMpk1 pathway as a whole, and not by the state of a certain protein 
kinase.55 
C inheritance in the growing mycelium requires not only the PaMpk1 pathway, but also increased 
translational accuracy and some genes encoding NADPH oxidases.53,55 Moreover, C can be cured by
various stresses, including heat, UV light, some antibiotics, and high concentrations of sucrose.52 
The exact mechanisms of these effects are still obscure, but the appearance and the dissipation of C 
are undoubtedly under complex genetic, developmental and environmental control. The difference 
between C produced during the growing and the stationary phases is of special interest: the first is 
both infectious and heritable, while the second is only infectious.
Up to date, C remains the only known example of heritable unit caused by post-translational protein
modification. However, since protein-based inheritance has been discovered just recently, other 
examples are possible. Theoretically, they can be determined by various types of protein 
modification, not only phosphorylation.    
Reproducible alterations in quaternary protein structure. The unique example of this 
mechanism known so far has been described in the Saccharomyces yeast. It involves the complex of
two non-homologous proteins: Pma1, an essential highly abundant P-type ATPase, and Std1, a 
component of the Snf3/Rgt2 regulatory pathway. Normally, Pma1 is associated mostly with the 
Std1 paralog Mth1. When Pma1 preferable interaction occasionally shifts from Mth1 to Std1, an 
abnormal protein complex designated as prion [GAR+] forms and reproduces (Figure 2B).57 
Recently, it has been shown that [GAR+] is also induced by the presence of unknown bacterial 
chemical factors.58
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In the [GAR+] cells, glucose repression is modified: these cells can grow in glycerol in presence of 
non-metabolizable glucose analog, glucosamine.57 This phenotype is transmissible via cytoduction, 
and is steadily inherited both mitotically and meiotically. [GAR+] formation is enhanced under 
STD1 or PMA1 overexpression, while MTH1 overexpression leads to the opposite effect. After 
[GAR+] is established, it can be reversibly cured by transient lack of Hsp70 proteins Ssa1 and Ssa2. 
Moreover, [GAR+] is totally cured when both STD1 and the N-terminus of PMA1 are deleted, but it 
reproduces in case only one of them is absent.57 Thus, the exact molecular mechanism of [GAR+] 
manifestation is unknown to date.
Positive feedback through alterations in primary protein structure. In all above mechanisms, 
the differences between the native and prion states do not affect primary protein structure. [β+], a 
self-activating form of yeast protease B, is the unique example of the opposite situation.59 Protease 
B (PrB) is derived from a large catalytically inactive zymogene encoded by the PRB1 gene and 
undergoes several steps of maturation.60 At final steps, the zymogene is truncated by protease A 
(PrA) and then by PrB itself: the mature molecules truncate the immature ones, thus producing a 
positive feedback loop.61 
The effectiveness of this loop depends on several genetic and environmental factors. On YPAD 
medium, PrB self-activation is PrA-dependent.62 As a result, deletion of PEP4 (the gene coding for 
PrA) leads to gradual decrease and eventual loss of active PrB; however, this loss is delayed, and 
the residual PrB activity lasts at least for 20 mitotic divisions. This effect is called “phenotypic 
lag”.63 On YPG medium, PrB is autonomous and does not require PrA activity; so, the cells display 
steady PrB self-activation even when PEP4 is deleted. When such cells are transferred to YPAD, 
they eventually lose active PrB and fail to restore it after return to YPG (strictly speaking, the 
restoration is possible, but it requires PRB1 overexpression). Thus, when PRB1 is normally 
expressed, two kinds of cells having exactly the same DNA background and differing only in their 
PrB state can be obtained on YPG medium: PrB positive ([β+]) and PrB negative ([β–]).59 
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 [β+] is stably heritable in both mitotic and meiotic generations, and can be effectively transmitted 
by cytoduction. So far, it is the unique hereditary factor reproducing through protein primary 
structure changes.      
  
The bimodularity principle of hereditary prion alleles
According to conventional criteria, hereditary prions are (i) non-Mendelian elements, (ii) reversibly 
curable by anti-prion agents, (iii) depending on the corresponding gene, and (iv) capable to appear 
de novo when this gene is overexpressed.26 The third point is of special importance for us. It means 
that allelic hereditary prions obligatorily depend on the same gene, and here is the way to uncover 
their allelism. For example, no [URE3] allele can be reproduced under the lack of the URE2 gene, 
and hereby any of them is quickly lost.26 So, all hereditary prions which are irreproducible in this 
DNA background should be considered as [URE3] alleles. 
Without taking the fourth criterion into account, dependence on the same gene does not guarantee 
prion allelism yet: non-allelic hereditary prions may require the same molecular function for their 
multiplication, as in case of [PSI+], [PIN+] and [URE3], which are lost under HSP104 deletion (for a
review see ref. 13). Therefore, to prove that certain hereditary prions are allelic to each other, both 
the third and the fourth criteria should be met. This approach is successful even for those prion 
alleles which significantly differ in their manifestation, like strong [PSI+] and [ETA+].49 
It is obvious from the above criteria that to perpetuate a certain [PRION+] allele, two kinds of 
molecular structures are required: (i) the protein structure (chemically modified, truncated or 
conformationally altered) as a seed, and (ii) the corresponding DNA sequence, otherwise the prion 
will not be reproduced due to the lack of the necessary protein. So, a [PRION+] allele is a bimodular
hereditary system that depends on the certain DNA sequence (DNA determinant) and the certain 
epigenetic mark (epigenetic determinant). The first encodes the prion protein sequence, while the 
second describes the state of this material, and both affect prion functions and evolution.64 Notably, 
the presence of a certain [PRION+] allele in a cell does not mean that all molecules of the 
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corresponding protein are transformed into the prion state: some portion of the native protein is also
retained.65–67 So, the symbol [PRION+] signifies the availability of specific epigenetic mark, which 
is absent in the [prion–] cells.
One can distinguish three types of differences between prion alleles. In the simplest case, these 
differences are solely of epigenetic origin, like between strong and weak [PSI+] variants 
independently produced in the same SUP35 background.14 Such prion alleles are encoded by the 
identical DNA determinant and vary just in epigenetic marks. On the contrary, some prion alleles 
are identical in their epigenetic mark, but differ in the DNA determinant. This is typical to 
cytoductants with various SUP35 backgrounds to which the same [PSI+] template has been 
transmitted.20,68 And finally, in most complicated cases, the differences between prion alleles affect 
both DNA and epigenetic determinants. The two distinct [PSI+] prion variants are remarkable 
example: the strong one produced by the normal SUP35 molecules, and the weak one induced in the
SUP35PNM2 background (hereafter referred as strong [PSI+] and [VH-1], respectively).14,15 The fact 
that even such prion variants are allelic to each other can be proven by the following simple logic. 
[VH-1] is reproducible in the normal SUP35 background.15 This leads to the appearance of a new 
prion variant with altered DNA determinant but the same epigenetic mark. The new prion variant (it
will be designated here as [VH-1]new) is allelic to [VH-1] since they differ in the DNA determinant 
only. Meanwhile, [VH-1]new is allelic to strong [PSI+]: both are encoded by the same DNA 
determinant and differ just in epigenetic marks. As a result, [VH-1] is allelic to [VH-1]new, and 
[VH-1]new is, in turn, allelic to strong [PSI+]; this means that [VH-1] and strong [PSI+] are allelic as 
well. 
Thus, prion alleles are considerably more sophisticated hereditary factors compared to DNA alleles 
or epialleles. Prion alleles are bimodular: their diversity displays variation in both DNA and 
epigenetic determinants, and alteration in either of these determinants can result in the appearance 
of a new prion allele. So, we propose bimodular designation of each prion allele: “DNA determinant
[epigenetic determinant]”. It should be especially noted that the DNA determinant is not a part of 
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prion allele; its presence in a certain bimodular designation just definitely describes the 
corresponding protein sequence. 
Usually both determinants of a certain prion are represented by a set of multiple variants, and each 
combination corresponds to a potential prion allele. This diversity is restricted by cell lethality or 
prion loss in specific combinations (see below). Some prion alleles are distinct in their 
manifestation, while some are phenotypically indistinguishable from each other, like DNA 
sequences with synonymous polymorphism. 
Implications of the bimodularity principle for the [PSI+] prion
As noted above, [PSI+] exists in multiple alleles distinct in their mitotic and meiotic stability, 
nonsense-suppressor efficiency, the proportion of aggregated Sup35p, the number of propagons per 
cell, and some other properties. In addition, the absence of the prion particles is considered as a 
null-allele, [psi–]. The aim of the following sections is to overview the principal variety of prion 
alleles and potential types of their interactions on the example of the [PSI+] prion. 
Prion alleles corresponding to the [psi–] state. We propose to distinguish three classes of [psi–] 
alleles. The first one corresponds to the reference SUP35 sequence peculiar to laboratory strains 
(SUP35ref; including known natural polymorphism; for a review see ref. 20) and native Sup35p; in 
this case, a cell possesses the appropriate DNA determinant but lacks the conformational template 
(SUP35ref[psi–]). If such null-allele is supplemented with aggregated Sup35p of a normal protein 
sequence (SUP35ref[PSI+]), it undergoes epigenetic conversion to the [PSI+] state. Depending on 
which conformational template is transmitted (strong or weak, [PSI+]S or [PSI+]W, respectively), the 
initial null-allele can be converted to different SUP35ref[PSI+] alleles (for a review see ref. 69). 
Various [PSI+] templates with altered protein sequence are also reproducible in the SUP35ref 
background and provide epigenetic conversion of SUP35ref[psi–] as well.15,20 At least one exception 
is currently known: SUP35ref fails to reproduce [PSI+] with the double substitution Q89K,Q90K.70 
Thus, SUP35ref[psi–] is convertible to the [PSI+] state by many but not all conformational templates. 
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Another class of [psi–] alleles lacks both the conformational template and the DNA determinant. To 
be clear, SUP35 is essential and therefore cannot be deleted as a whole; however, the N-terminal 
region of Sup35p does not affect viability but is required for the Sup35p prionization.71,72 So, the N-
truncated SUP35 (SUP35ΔN) is insufficient for [PSI+] formation and will be further referred as the 
DNA N-determinant absence. When SUP35ΔN[psi–] is supplemented with any [PSI+] through 
cytoduction or protein transformation, the transmitted prion particles do not receive the material for 
growth and therefore are not reproduced69 ([PSI+]R–). As a result, the SUP35ΔN[psi–] alleles are per 
se epigenetically inconvertible. 
The difference between the SUP35ref[psi–] and the SUP35ΔN[psi–] alleles is also evident by their 
ability to revert to the [PSI+] state. SUP35ref[psi–] undergoes rare spontaneous reversions to 
SUP35ref[PSI+], and these events are strongly enhanced under the DNA N-determinant 
overexpression.14 The reversion mechanism is still obscure; it admittedly relates to stochastic shifts 
from the native Sup35p conformation to the amyloid one, and another amyloid prion, [PIN+], is 
required as an initial template for Sup35p aggregation.73 Usually, various SUP35ref[PSI+] alleles can 
arise on the same SUP35ref[psi–] background;14,15,17 so, the shift to the amyloid conformation may 
occur in several alternative ways, with some distinctions in the eventual folding (for a review see 
ref. 13). On the contrary, SUP35ΔN[psi–] is completely irreversible because of the lack of the DNA 
N-determinant. 
In the third, intermediate, class of [psi–] alleles, the DNA N-determinant is present, but its sequence 
is altered compared to SUP35ref due to point mutations or local deletions (SUP35alt). To the best of 
our knowledge, all SUP35alt[psi–] alleles published so far are reversible. Moreover, they are 
epigenetically convertible to the [PSI+] state, but specific conformational templates are usually 
required. One of the most famous examples is SUP35PNM2[psi–]: although it is able to form and 
perpetuate several specific conformational templates, it leads to loss of some SUP35ref[PSI+].15,74,75 
Similar features are characteristic to [psi–] alleles with sup35-M1 (Y46K/Q47K) or sup35-M2 
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(Q61K/Q62K) affecting the first and the second oligonucleotide repeats in the DNA N-determinant 
respectively.70 
Inability of a certain SUP35alt[psi–] allele to undergo epigenetic conversion by particular [PSI+] 
templates may also be due to lethality of these combinations. For example, sup35-2 is lethal with 
atypical [PSI+] initially called [ETA+]76 but is compatible with SUP35ref[PSI+]S.49 The point T341D 
mutation which affects the C-terminal region of Sup35p causes lethality with SUP35ref[PSI+]; 
however, the lethal effect is ceased when the DNA N-determinant is absent or unable to provide 
prionization.77 Thus, the features of the prion alleles are conditioned by both N- and C-terminal 
regions of Sup35p. In theory, some completely irreversible and inconvertible SUP35alt[psi–] alleles 
may exist, but none has been discovered so far. 
Prion alleles corresponding to the [PSI+] state. A certain [PSI+] allele is the bimodular system 
where native Sup35p molecules involved in [PSI+] reproduction are encoded by a certain DNA 
determinant. So, by indicating this determinant for a [PSI+] allele, we give definite description of 
the prion protein sequence. For example, SUP35ref[PSI+] designates a [PSI+] allele in which prion 
particles are produced by the Sup35p molecules with reference protein sequence. Since different 
conformational templates can be derived from the same DNA determinant,14,15,17 additional 
specifying notes, like SUP35ref[PSI+]S or SUP35ref[PSI+]W, are required. Also, in some SUP35 
backgrounds encoding only the N-domain of Sup35p (for example, SUP351-123 with additional 
SUP35ΔN to provide viability), all [PSI+] templates become undifferentiated, [PSI+]U.69
In most well-studied [PSI+] alleles, the DNA determinant is SUP35ref. Such alleles may significantly
differ in their properties;14,15,17,49 all distinctions are conditioned here by conformational templates 
specificity.41–43 [PSI+] alleles with the SUP35alt DNA determinant are also known, and they are 
strongly variable depending on both determinants.20 
Interaction between different [psi–] alleles. If a diploid cell has got two different [psi–] alleles 
from the parent strains (similar situation can be modeled in a [psi–] haploid carrying two distinct 
copies of SUP35), these null-alleles should interact with each other with respect to their 
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reversibility to the [PSI+] state. Depending on the combined null-alleles, the results of interaction 
may be diverse. We will focus just on several examples. 
In the simplest cases, clear dominance is expected. For instance, when one null-allele is reversible 
and another is irreversible (SUP35ΔN[psi–]), the first should dominate over the second. However, this
effect cannot be detected in common way through arising of colonies with [PSI+]-mediated 
nonsense suppression, since N-truncated Sup35p is never included in the prion particles and thus 
provides adequate termination at nonsense codons.69
Dominance may also take place when each null-allele is reversible alone, but one of them has PNM 
(“psi-no-more”) manifestation. Indeed, if this effect of a certain SUP35PNM encompasses all possible
SUP35ref[PSI+] templates, the reversions occurred in the SUP35ref[psi–]/SUP35PNM[psi–] heterozygote
should arise via PNM-compatible templates only, and SUP35PNM[psi–] will dominate over 
SUP35ref[psi–]. But when no PNM mutation is involved, each reversible null-allele can participate in
the [PSI+] state production, thus displaying some kind of co-dominant manifestation.
Two different [psi–] alleles may also interact with each other in their convertibility to the [PSI+] 
state, but here the transmitted conformational template is required. So, this phenomenon is per se 
very close to interaction between [PSI+] and [psi–] alleles, and will be considered in the following 
section.
Interaction between [PSI+] and [psi–] alleles. The simplest model to study such interaction is 
diploids produced by SUP35ref[PSI+] x SUP35ref[psi–] crosses. In these diploids, [PSI+] dominates in 
all aspects of its manifestation.50,78 Moreover, epiheterozygosity for [PSI+] brings to protein 
paramutation: [psi–] undergoes epigenetic conversion to [PSI+], and tetrad analysis typically gives 
non-Mendelian 4[PSI+] : 0[psi–] segregation (for a review see ref. 22). 
If two prion alleles combined in a [PSI+] x [psi–] hybrid considerably differ in their DNA 
determinants, interaction between them may be more complex. For example, in the 
SUP35ref[PSI+]/SUP35ΔN[psi–] heterozygote, the first prion allele is dominant for [PSI+] 
reproduction and recessive for nonsense-suppression (see above). All ascospores produced by such 
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heterozygotes receive SUP35ref[PSI+], but in the SUP35ΔN segregants, the transmitted prion particles
are quickly lost, resulting in Mendelian 2[PSI+] : 2[psi–] tetrads.72  
Theoretically, in some [PSI+] x [psi–] crosses, interallelic complementation may occur.  In this case, 
the conformational template of a weak [PSI+] allele should interact with the DNA determinant of a 
[psi–] allele providing strong [PSI+] formation. As a result, the initial [PSI+]/[psi–] heterozygosity 
will cease, and the cell will become the [PSI+]/[PSI+] heterozygote which possesses two different 
[PSI+] alleles with the same epigenetic mark but distinct in their protein sequences (see next 
section). 
Interaction between different [PSI+] alleles. When two distinct [PSI+] alleles are combined in a 
diploid hybrid, their interaction may occur in several ways depending on the nature of difference. In
the simplest case, both prion alleles are encoded by the same DNA determinant and differ just in 
their conformational templates, as in isogenic [PSI+]S x [PSI+]W diploids. All such diploids are 
phenotypically [PSI+]S, so the strong [PSI+] variant is dominant over the weak one. Only dominant 
segregants are revealed in tetrad analysis allowing to suggest that [PSI+]W is less competitive in 
reproduction than [PSI+]S and is eventually lost.50 However, Bateman and Wickner have 
demonstrated that at least in certain [PSI+] strains different conformational templates coexist in 
“clouds” and can be separated from each other via cytoduction. Thus, the fate of [PSI+]W alleles in 
isogenic [PSI+]S x [PSI+]W hybrids is still questionable.20
If the combined [PSI+] alleles differ in their DNA determinants but possess the same conformational
template (like SUP35PNM2[VH-1] and SUP35ref[VH-1]), three types of the prion particles should be 
produced. Two of them correspond to the initial [PSI+] alleles, and the third is mosaic; its amount 
depends on the efficiency of cross-templating. In tetrad analysis, the ascospores produced by such 
hybrids should contain a mixture of different [PSI+] particles, but further, at the level of growing 
colonies, clear 2 : 2 ratio must be established, reflecting meiotic segregation of the DNA 
determinants. Here, the initial [PSI+] alleles behave like classical Mendelian hereditary factors. 
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In most complicated cases, when the combined [PSI+] alleles differ from each other in both DNA 
and epigenetic determinants, various types of interaction are theoretically possible (Figure 3). They 
include (i) stable co-existence of the initial [PSI+] alleles (Figure 3A), (ii) appearance of mosaic 
particles and “recombinant” [PSI+] alleles in addition to the initial ones(Figure 3B), and (iii) 
competition between the initial and/or recombinant [PSI+] alleles leading to eventual loss of the 
weakest one(s) (Figure 3C). Depending on the type of these interactions in certain diploid, the 
results of tetrad analysis may differ. 
Combination-specific interplays between the DNA and epigenetic determinants in the [PSI+] 
cells. Three types of such interplays are currently described. First, some combinations are lethal;49,77 
the mechanism of this phenomenon is still under discussion (for a review see ref. 79).
Second, in some combinations, the [PSI+] particles are eventually lost, although the DNA 
determinant is quite appropriate for other [PSI+] templates. The most famous example is elimination
of certain SUP35ref[PSI+] alleles in the SUP35PNM2 background.15,70,74,75,80,81 Interestingly, the 
“reciprocal” combinations are quite stable: overproduction of SUP35PNM2 induces the rise of specific
SUP35PNM2[PSI+] alleles, templates of which are efficiently reproduced by SUP35ref.15
In theory, combination-specific [PSI+] loss may also occur due to positive selection of the [psi–] 
state: if the [PSI+] state is both unstable and lethal, only the [psi–] derivates should survive, and the 
resulting cell culture will be totally cured. So, the second type of the interplays may be provided by 
different mechanisms.
Third, the interplay can lead to [PSI+] template modification. For instance, the double substitution 
Q80K,Q81K significantly strengthens the template of SUP35ref[PSI+], and this effect is preserved 
even after prion transmission to the initial SUP35ref background. The double substitution 
Q89K,Q90K gives an opposite effect (sup35-M5 mutation). Notably, the conformational template of
the resulting sup35-M5[PSI+] allele fails to reproduce on the initial SUP35ref background, thus 
manifesting the second type of the interplays.70,82 So, transmission of a certain [PSI+] allele from one
DNA determinant to another and back is sometimes not a “true reversion”.   
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In the third type of the interplays, each combination of the DNA and the epigenetic determinants, 
when isolated in a single cell, may behave as a separate prion allele. However, in the first and the 
second types, the corresponding combinations per se are not prion alleles because of their inability 
to perpetuate in the progeny due to either lethal effect or [PSI+] to [psi–] conversion. 
Non-multiplied or non-reproduced states of [PSI+] alleles. Under the lack of Hsp104 chaperone 
function (for example, during GuHCl treatment or in strains with HSP104 deletion), the [PSI+] 
particles are not multiplied, and fail to produce new prion seeds.39,40,83,84 As a result, the non-
multiplied [PSI+] particles (we propose to designate them by subscript, [PSI+]M–) are progressively 
diluted in cell divisions, and after approximately 15 cell cycles the overwhelming majority of the 
mitotic progeny is cured.40,84,85 But the residual amyloid fibrils do not vanish: due to continuous 
Sup35p aggregation, they become extra long and usually remain in the mother cell because of 
asymmetric division in the Saccharomyces yeast.86 However, the initial [PSI+] allele appears to be 
intact, and may be multiplied and inherited after Hsp104 function is restored.40,84,85 Thus, the 
[PSI+]M– particles are hereditary factors, which retain their allelic specificity and can be potentially 
rescued for the progeny. We should also mention that [PSI+] multiplication depends on the balance 
between various cellular chaperones, and any disturbance of this machinery may have remarkable 
consequences on the prion properties.87–92
In theory, the [PSI+]M– state may exist even under normal chaperone function. This state could be 
characteristic to SUP35 mutants in which the produced prion particles are not amenable for 
chaperone-mediated cleavage as a result of some defects in the Sup35p N-terminal region. 
However, such mutants are still unknown. And even if they do exist, the corresponding particles 
should be quickly cleared from the culture due to infinite enlargement and poor heritability.  
Another atypical state of [PSI+] alleles can be obtained when the prion particles are transmitted to a 
cell lacking both Hsp104 function and the DNA N-determinant. Under these conditions, when the 
[PSI+] particles are neither reproduced nor multiplied ([PSI+]R–M–), the overwhelming majority of the
mitotic progeny should be SUP35ΔN[psi–], while some cells can retain a single or few prion particles.
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The [PSI+]R–M– amyloid fibrils do not enlarge and thus are potentially heritable. They can be rescued 
through cytoduction to a SUP35ref recipient with normal Hsp104 function. 
The non-reproduced state of a [PSI+] allele resembles “canonical” DNA allele in a non-replicative 
plasmid: both will be eventually lost in cell divisions, but might be rescued under specific 
conditions. This similarity gives additional support to applying the term “allele” for hereditary 
prions.
Implications of the bimodularity principle for other hereditary prions
Allelic diversity of amyloid hereditary prions other than [PSI+] is less studied. However, the 
bimodularity principle is fully applicable to these prions also, as can be demonstrated by 
[URE3] and [PIN+]. 
First, they depend on certain DNA determinants (URE2 and RNQ1, respectively), and deletion 
of these genes lead to establishment of corresponding [prion–] alleles (both deletions are not 
lethal).34,93 Second, Ure2p and Rnq1p with reference protein sequence can form multiple 
[URE3] or [PIN+] alleles differing in their phenotypic manifestation.50,94–96 Third, alterations in 
the DNA determinant (point mutations or local deletions) may affect formation, stability, or 
phenotypic manifestation of prion allele, at least in [PIN+].97–100 Thus, [URE3] and [PIN+] allele
depend on both DNA and epigenetic determinants.
Non-amyloid hereditary prions (C, [GAR+] and [β+]) are also covered by the bimodularity 
principle. There are just three details to be mentioned. First, reproduction and multiplication of 
such prions are not separated from each other: it is the same molecular process. Second, as 
long as reproduction (multiplication) of non-amyloid hereditary prions is based on positive 
feedback loops without conformational templates (see above), their epigenetic determinants are
of non-template nature. This does not impede the existence of different [PRION+] epigenetic 
marks. For example, C requires all three components of the PaMpk1 pathway and is admittedly
represented by the self-activating state of the whole cascade;55 in that case, the DNA 
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determinant seems to be triple, PaASK1––PaMKK1––PaMpk1. Deletion or dysfunction of any 
gene involved in such DNA determinant should result in irreversible and inconvertible [prion–] 
allele. [GAR+] is provided by physical interaction between two non-homologous proteins Pma1
and Std1;57 so, the corresponding DNA determinant is likely binary, PMA1––STD1. However, 
since [GAR+] reproduces under STD1 deletion,57 the exact molecular basis of this prion is still 
questionable.
Conclusions
In this paper we have further developed the ideas of Chernoff and Tuite about prion alleles.21,22 
Prion allele is considered as a bimodular hereditary system which depends on a certain DNA 
sequence (DNA determinant) and a certain epigenetic mark (epigenetic determinant). The first 
encodes the prion protein sequence, while the second reflects the presence or absence of specific 
prion seeds. Bimodular designation of each prion allele (DNA determinant[epigenetic determinant])
is accordingly proposed. 
It has been widely accepted that prions are “protein-only” hereditary factors. This is true in vitro, 
where native molecules of a certain prion protein are placed, and the only factor required for their 
prionization is addition of the corresponding prion seeds. But in vivo the situation differs markedly: 
when the DNA determinant is absent and native molecules are also lacking, there is no material for 
prionization even if the prion seeds are transferred to the cell. Thus, the “protein-only” concept is 
not universal and should be replaced by the bimodularity principle. 
This principle is an appropriate generalization in prion studies, and its foresights can be found at 
least in several prion-related papers. For instance, amyloid prions are sometimes considered as 
conformational (“second order”) templates in addition to DNA (“first order”) ones.4,101,102 This view 
is quite close to the bimodularity principle, but does not cover non-amyloid hereditary prions which 
reproduce via positive feedback loops without second order templates. The fact that prion function 
and evolution are affected at two levels (DNA and protein) has been recently pointed out by 
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Wickner and Kelly.64 Notably, Bateman and Wickner denote the origin of different [PSI+] alleles (A,
F and G) produced in the same SUP35 background (E9) as [PSI+E9A], [PSI+E9F] and [PSI+E9G].20 
This approach is very similar to ours, but the DNA determinant is included within square brackets 
and thereof looks like an element of the prion protein. However, when a certain [PSI+] allele (for 
example, [PSI+E9A]) is transmitted to another SUP35 background (Δ19 or ref), the resulting prion 
alleles are designated as [PSI+E9A]Δ19 and [PSI+E9A]ref, where the initial DNA determinant is 
written within square brackets and the new one is not. The bimodularity principle is devoid of the 
aforementioned disadvantages. It gives useful and consistent designations of the DNA and 
epigenetic determinants, prion alleles, their alterations, non-multiplied and non-reproduced states, 
etc. (Table 2). Moreover, it is applicable to any hereditary prion allele, whenever it is amyloid or 
non-amyloid. 
In accordance with the bimodularity principle, we distinguish three types of prion allele differences.
They may affect the DNA determinant only, the epigenetic determinant only, or both. As a result, 
multiple [PRION+] and [prion–] alleles can exist. Some of them are phenotypically distinct, while 
others are similar in their manifestation, like DNA sequences with synonymous polymorphism. 
Although prion alleles are considerably more complex hereditary factors compared to DNA alleles 
and epialleles, there are a lot of remarkable similarities. Like “canonical” DNA alleles, prion alleles 
are multiple and highly polymorphic. They can transiently exist in the non-reproduced state similar 
to “canonical” DNA alleles expressed in a non-replicative plasmid. Alteration of a [PRION+] allele 
due to substitution of the DNA determinant is not a single-stage process resembling pre-mutational 
DNA mismatch. Some prion alleles (for example, isogenic [PSI+]S and [PSI+]W) are dominant and 
recessive, respectively, in the heterozygote. Moreover, in crosses like SUP35ref[PSI+] x 
SUP35ΔN[psi–], the combined prion alleles show clear Mendelian segregation. 
Like epialleles, isogenic [PRION+] and [prion–] alleles differ from each other just epigenetically. 
Moreover, being combined in a heterozygote, they are involved in paramutation establishment. 
Thus, the term “prion allele” is appropriate for modern genetics. 
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It should be especially noted that the bimodularity principle is applicable not only for hereditary 
prion alleles, but for any epigenetic hereditary factor (Table 3). So, this is an important step towards
universal genetic concepts which should embrace all variety of hereditary factors irrespective of 
their molecular nature.  
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Figure legends
Figure 1. Main processes underlying heredity of amyloid prions. Mother cell and developing bud
are separated by dashed line.
Figure 2. Molecular basics of [GAR+] and  C. A. The state of the PaMpk1 pathway in absence or
presence of C. B. Preferable interactions of the Pma1 protein in the [gar-] and [GAR+] strains.57 
Figure  3.  Possible  interactions  between  [PSI+]  alleles  in  heterozygote  when  both  DNA  and
epigenetic  determinants  are  distinct.  A.  No  cross-seeding  between  different  conformational
templates  occurs;  only  the  initial  prion  alleles  coexist.  B.  Cross-seeding  between  different
conformational templates leads to prion allele recombination. The initial prion alleles coexist with
two recombinant ones. C. Only one of recombinant prion alleles is stable.
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Tables
Table 1. Molecular mechanisms underlying formation and reproduction of hereditary prions 
Mechanism Prion Protein determinant Phenotypic effect Organism Refs.
Switch from native to amyloid 
conformation
[URE3] Ure2 Alteration of nitrogen metabolism S. cerevisiae 26
[PSI+] Sup35 Nonsense suppression S. cerevisiae 26,48
[Het-s] Het-s Heterokaryon incompatibility in fuses with Het-S
mycelium
P. anserina 103
[PIN+] Rnq1 Induction of [PSI+] de novo formation S. cerevisiae 73
[SWI+] Swi1 Alteration of carbon metabolism S. cerevisiae 104
[MOD+] Mod5 Drug resistance and cell survival under environmental
stress
S. cerevisiae 38
Positive feedback through protein 
phosphorylation 
C PaMpk1 cascade Crippled growth P. anserina 53
Reproducible alterations in protein 
quaternary structure
 [GAR+] Pma1 and Std1 Heritable switch in carbon source utilization S. cerevisiae 57
Positive feedback through alteration
in protein primary structure
 [β+] PrB1 Constant activity of protease B S. cerevisiae 59
Table 2. Proposed abbreviations of prion alleles, their determinants, alterations and states on the example of prion [PSI+] 
Described parameter Designation (a) Genetic notion
DNA determinants SUP35ref Reference SUP35 sequence typical for laboratory strains, with natural 
polymorphism  
SUP35alt SUP35 sequence differing from SUP35ref due to point mutations or local 
deletions (for example, SUP35PNM2)
SUP35ΔN SUP35 sequence lacking the N-domain coding region
Epigenetic determinants [psi–] Absence of Sup35p amyloid state (prion null-allele)
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[PSI+] Presence of Sup35p amyloid state 
[PSI+]S Presence of conformational template corresponding to a strong prion variant
[PSI+]W Presence of conformational template corresponding to a weak prion variant 
Prion alleles SUP35ref[PSI+] [PSI+] allele encoded by SUP35ref 
SUP35alt[PSI+] [PSI+] allele encoded by SUP35alt
SUP35ref[psi–] Prion null-allele encoded by SUP35ref
SUP35alt[psi–] Prion null-allele encoded by SUP35alt
SUP35ΔN[psi–] Prion null-allele encoded by SUP35ΔN
Alterations of prion 
alleles
SUP35ref[psi–→PSI+] Alteration of a SUP35ref[psi–] allele due to [PSI+] induction or epigenetic 
conversion 
SUP35alt[psi–→PSI+] Alteration of a SUP35alt[psi–] allele due to [PSI+] induction or epigenetic 
conversion 
SUP35ref[PSI+→psi–] Prion null-allele induction in a SUP35ref[PSI+] cell via prion curing
SUP35alt[PSI+→psi–] Prion null-allele induction in a SUP35alt[PSI+] cell via prion curing
SUP35ref→alt[PSI+] Alteration of a [PSI+] allele via replacement of SUP35ref with SUP35alt by 
transformation or cytoduction (b)
SUP35 alt→ref[PSI+] Alteration of a [PSI+] allele via replacement of SUP35alt with SUP35ref by 
transformation or cytoduction (b)
SUP35ref→1-123[PSI+]S→U Double alteration of the SUP35ref[PSI+]S or SUP35ref[PSI+]W allele after its 
transmission to the SUP351-123 background: replacement of the DNA 
determinant and dedifferentiation of the [PSI+] template 
SUP35ref→1-123[PSI+]W→U 
SUP351-123→ref[PSI+]U→S Double alteration of the SUP351-123[PSI+]U allele after its transmission to the 
SUP35ref background: replacement of the DNA determinant and spontaneous
differentiation of the [PSI+] template
SUP351-123→ref[PSI+]U→W
Prion allele states [PSI+]R– Non-reproduced state of a [PSI+] allele
[PSI+]M– Non-multiplied state of a [PSI+] allele
[PSI+]R–M– Non-reproduced and non-multiplied state of a [PSI+] allele
Homozygotes SUP35ref[psi–]/SUP35ref[psi–] Homozygote for prion null-allele encoded by SUP35ref
SUP35alt[psi–]/SUP35alt[psi–] Homozygote for prion null-allele encoded by SUP35alt
SUP35ΔN[psi–]/SUP35ΔN[psi–] Homozygote for prion null-allele encoded by SUP35ΔN
SUP35ref[PSI+]/SUP35ref[PSI+]     Homozygote for a [PSI+] allele encoded by SUP35ref
SUP35alt[PSI+]/SUP35alt[PSI+]     Homozygote for a [PSI+] allele encoded by SUP35alt
Heterozygotes (c) SUP35ref[psi–]/SUP35alt[psi–] Heterozygote for different [psi–] alleles
SUP35ref[PSI+]/SUP35ΔN[psi–] Heterozygote for a [PSI+] allele and inconvertible [psi–] allele
2828
SUP35ref[PSI+]S/SUP35ref[PSI+]W Heterozygote for two [PSI+] alleles distinct in their epigenetic determinants 
(cloud heterozygote) (d) 
SUP35ref[PSI+]/SUP35alt[PSI+] Heterozygote for two [PSI+] alleles distinct in their DNA determinants (e)
SUP35ref[PSI+]’/SUP35alt[PSI+]” Heterozygote for two [PSI+] alleles distinct in both DNA and epigenetic 
determinants; no cross-seeding (Fig. 3A)
Alterations of initial 
prion allele 
combinations 
[PSI+]/[psi–→PSI+ ]   Paramutation in initial [PSI+]/[psi–] heterozygote (f) 
[PSI+]’/[PSI+]”→’ Homozygotisation of the [PSI+] conformational template in initial [PSI+]’/
[PSI+]” heterozygote via epigenetic conversion (f)
SUP35ref[PSI+]’/SUP35alt[PSI+]”;rec Cross-seeding between two [PSI+] alleles distinct in both DNA and 
epigenetic determinants leads to their recombination. As a result, initial 
prion alleles coexist with two recombinant ones (fig. 3B)   
SUP35ref[PSI+]’/SUP35alt[PSI+]”;recref” Only one of recombinant [PSI+] alleles is stable (fig. 3C) 
SUP35PNM2[psi–]/SUP35ref[PSI+→psi–] Spontaneous [PSI+] loss in initial [psi–]/[PSI+] heterozygote 
(a)   The simplest situations are considered. To describe more complicated ones, the proposed designations should be combined appropriately. 
(b)   Alteration of a [PSI+] allele due to substitution of the DNA determinant is not a single-stage process. If the new DNA determinant is
compatible with the initial conformational template, the prion fibrils become mosaic; they contain two Sup35p variants (“old” and “new”),
and the portion of the former gradually grows up. This eventually results in complete loss of the “old” Sup35p variant, and from that
moment the new [PSI+] allele is established. Notably, the transitional stage between “old” and “new” prion alleles corresponds to classical
pre-mutational DNA mismatch where the bases of both “old” and “new” alleles are simultaneously present. The main difference is that in
case of prion alleles, the transitional stage is gradual and more prolonged.    
(c)   For each type of heterozygotes, only one certain example is shown. If a heterozygote is produced by genetic cross, the first written prion
allele is of MATα parent. If a heterozygote is produced by genetic transformation of a haploid strain, the first written prion allele is
encoded by chromosomal DNA determinant.
(d)   Cloud heterozygocity may also occur in a single DNA determinant background (SUP35ref[PSI+]S,W).
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(e)   When two [PSI+] alleles have the same epigenetic determinant, the corresponding Sup35p variants may co-aggregate producing a wide
spectrum of mosaic fibrils. This situation resembles the transitional stage between two prion alleles (see note 1), but here none of them is
eventually lost. The mosaic fibrils display the same hereditary features as a mix of the pure ones and therefore are not to be considered as
new prion alleles. 
(f)   Such alterations may occur on either SUP35ref or SUP35alt backgrounds. 
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Table 3. Bimodularity of non-prionic epigenetic alleles
Mechanism Organism Certain allele DNA determinant Epigenetic determinant Refs.
DNA methylation Arabidopsis
thaliana
BAL epimutation BAL region of the
chromosome 4
Hypomethylation of the BAL region 105
Wild type Normal methylation of the BAL region 
Histone 
modifications
A. thaliana FLC silenced by
vernalization
FLC region of the
chromosome 5
H3K27me3 associated with the FLC region 106
Wild type Non-methylated H3K27 associated with the FLC
region 
Positive feedback 
by means of 
transcription 
factors
E. coli ON state of the
bistable lac operon
The lacY and the lacI
genes 
Absence of the lac repressor 107
OFF state of the
bistable lac operon
Presence of the lac repressor
Inhibition of 
translation in 
plastids by 
antibiotics
Nicotiana
tabacum
Inherited albino
phenocopy
Plastid genes for
ribosomal proteins
Absence of plastid ribosomes 108
Wild type Presence of plastid ribosomes 
Reproducible 
differences in 
cortex structure
Paramecium
sp.
Inverted ciliary rows The genes encoding
cortical proteins 
Inverted position of ciliary basal bodies 109
Wild type Wild type position of ciliary basal bodies
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[GAR+][gar-]
Pma1 Pma1
Std1 Std1
Std1Std1
Mth1 Mth1
Mth1Mth1
PaAsk1
Std1Mth1
PaMkk1
PaMpk1
Self-sustained activation 
of kinase pathway
A
B
PaAsk1
PaMkk1
PaMpk1
OFF (no C) ON (C)

